Spain · Delayed Price · Currency is EUR Labiana Health Statistics
Total Valuation
Labiana Health has a market cap or net worth of EUR 60.32 million. The enterprise value is 91.56 million.
| Market Cap | 60.32M |
| Enterprise Value | 91.56M |
Important Dates
The last earnings date was Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Labiana Health has 8.26 million shares outstanding. The number of shares has decreased by -0.65% in one year.
| Current Share Class | 8.26M |
| Shares Outstanding | 8.26M |
| Shares Change (YoY) | -0.65% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.50% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 56.47 and the forward PE ratio is 16.30.
| PE Ratio | 56.47 |
| Forward PE | 16.30 |
| PS Ratio | 0.84 |
| PB Ratio | 16.74 |
| P/TBV Ratio | 14.06 |
| P/FCF Ratio | 898.47 |
| P/OCF Ratio | 18.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of 1,363.79.
| EV / Earnings | 101.25 |
| EV / Sales | 1.28 |
| EV / EBITDA | 9.76 |
| EV / EBIT | 14.64 |
| EV / FCF | 1,363.79 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 9.98.
| Current Ratio | 1.42 |
| Quick Ratio | 0.86 |
| Debt / Equity | 9.98 |
| Debt / EBITDA | 3.83 |
| Debt / FCF | 535.83 |
| Interest Coverage | 1.20 |
Financial Efficiency
Return on equity (ROE) is 23.11% and return on invested capital (ROIC) is 17.46%.
| Return on Equity (ROE) | 23.11% |
| Return on Assets (ROA) | 7.43% |
| Return on Invested Capital (ROIC) | 17.46% |
| Return on Capital Employed (ROCE) | 19.39% |
| Weighted Average Cost of Capital (WACC) | 7.53% |
| Revenue Per Employee | 181,915 |
| Profits Per Employee | 2,295 |
| Employee Count | 394 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 2.64 |
Taxes
| Income Tax | -278,386 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +140.13% in the last 52 weeks. The beta is 0.17, so Labiana Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +140.13% |
| 50-Day Moving Average | 4.92 |
| 200-Day Moving Average | 4.46 |
| Relative Strength Index (RSI) | 80.55 |
| Average Volume (20 Days) | 29,973 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Labiana Health had revenue of EUR 71.67 million and earned 904,362 in profits. Earnings per share was 0.13.
| Revenue | 71.67M |
| Gross Profit | 40.67M |
| Operating Income | 6.25M |
| Pretax Income | 573,797 |
| Net Income | 904,362 |
| EBITDA | 9.38M |
| EBIT | 6.25M |
| Earnings Per Share (EPS) | 0.13 |
Balance Sheet
The company has 3.77 million in cash and 35.97 million in debt, with a net cash position of -32.21 million or -3.90 per share.
| Cash & Cash Equivalents | 3.77M |
| Total Debt | 35.97M |
| Net Cash | -32.21M |
| Net Cash Per Share | -3.90 |
| Equity (Book Value) | 3.60M |
| Book Value Per Share | 0.65 |
| Working Capital | 9.19M |
Cash Flow
In the last 12 months, operating cash flow was 3.18 million and capital expenditures -3.11 million, giving a free cash flow of 67,138.
| Operating Cash Flow | 3.18M |
| Capital Expenditures | -3.11M |
| Depreciation & Amortization | 3.13M |
| Net Borrowing | 330,055 |
| Free Cash Flow | 67,138 |
| FCF Per Share | 0.01 |
Margins
Gross margin is 56.74%, with operating and profit margins of 8.73% and 1.26%.
| Gross Margin | 56.74% |
| Operating Margin | 8.73% |
| Pretax Margin | 0.80% |
| Profit Margin | 1.26% |
| EBITDA Margin | 13.09% |
| EBIT Margin | 8.73% |
| FCF Margin | 0.09% |
Dividends & Yields
Labiana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.65% |
| Shareholder Yield | 0.65% |
| Earnings Yield | 1.50% |
| FCF Yield | 0.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Labiana Health has an Altman Z-Score of 2.31 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.31 |
| Piotroski F-Score | 6 |